BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) (“Enzon”) announced that at a special meeting held this morning, its stockholders approved the sale of Enzon’s specialty pharmaceutical business to the sigma-tau Group (“sigma-tau”).
